MK-677 (Ibutamoren) Guide: Dosage, Benefits & GH/IGF-1 Breakdown
MK-677 (Ibutamoren)
MK-677 (Ibutamoren) is a growth hormone secretagogue studied for its ability to increase growth hormone (GH) and IGF-1 levels. It works by mimicking ghrelin, the body’s hunger hormone, leading to increased GH release, improved recovery, and potential changes in body composition.
How It Works
Ghrelin Receptor Activation ↑ → GH Release ↑ → IGF-1 ↑ → Recovery + Sleep + Growth Support
MK-677 stimulates the ghrelin receptor, which signals the body to increase natural growth hormone secretion. Unlike injectable GH, it works indirectly by enhancing the body’s own production.
Important Distinction
MK-677 is not a peptide.
It is an oral growth hormone secretagogue that works through ghrelin receptor activation.
It does not require reconstitution and is typically taken in capsule or liquid form.
MK-677 Research Protocol
Ghrelin Receptor Activation → GH Release ↑ → IGF-1 ↑ → Recovery + Sleep Support
Research framework:
The gradual 10–25 mg schedule below reflects commonly discussed research and community use. Human clinical trials have studied several doses of MK-677, with 25 mg once daily being one of the most commonly studied doses.
The gradual 10–25 mg schedule below reflects commonly discussed research and community use. Human clinical trials have studied several doses of MK-677, with 25 mg once daily being one of the most commonly studied doses.
Standard / Gradual Approach
Week 1–210 mg daily
Week 3–615 mg daily
Week 7+15–25 mg daily
Week 1–2
Starting Dose
Dose10 mg daily
FrequencyOnce daily
TimingNight or morning depending on goals
Week 3–6
Build
Dose15 mg daily
FrequencyOnce daily
Use ContextAssess hunger, water retention, sleep, and recovery
Week 7+
Standard / Higher Range
Dose15–25 mg daily
FrequencyOnce daily
Use ContextHigher-tolerance recovery or GH-support phase
Simple structure:
MK-677 is usually started low because hunger, water retention, lethargy, and blood sugar changes can be dose-dependent. A gradual build makes it easier to assess response before moving into higher ranges.
MK-677 is usually started low because hunger, water retention, lethargy, and blood sugar changes can be dose-dependent. A gradual build makes it easier to assess response before moving into higher ranges.
How to Use MK-677 (Cycle, Timing & Structure)
Research FrequencyOnce daily
Research RouteOral
Research TimingNight most common, morning if preferred
Research Cycle Length8–16+ weeks
ReconstitutionNot required
Best Time to Take
Night dosing is most common because it aligns with natural GH rhythm and may support sleep-focused goals.
Morning dosing may be preferred if night use causes hunger, vivid dreams, or sleep disruption.
Take consistently each day for the clearest tracking.
Timing can be adjusted based on hunger, sleep quality, lethargy, and appetite response.
When to Use
During recovery-focused phases
During sleep-support or GH-support phases
During body composition phases where appetite increase is manageable
As a longer support phase rather than a short “quick effect” cycle
Simple Strategy
Choose Timing by Side Effects
If hunger is strongest at night, morning dosing may feel better. If sleep and recovery are the main goals, night dosing is commonly preferred.
Track Response
Monitor hunger, water retention, blood sugar trends, sleep quality, and energy before increasing the dose.
Research note:
There is no clinically established requirement to cycle MK-677 or take a specific number of weeks off. Human studies have used continuous daily dosing for much longer periods, including up to two years. The shorter cycles and breaks shown here reflect community-style protocols used to reassess appetite, water retention, glucose response, and overall benefit.
There is no clinically established requirement to cycle MK-677 or take a specific number of weeks off. Human studies have used continuous daily dosing for much longer periods, including up to two years. The shorter cycles and breaks shown here reflect community-style protocols used to reassess appetite, water retention, glucose response, and overall benefit.
Clinical Research vs Real-World Use
Real-World / Community Use
Common Range
10–25 mg daily
Frequency
Once daily
Common Goals
GH support, recovery, sleep, body composition
Human Clinical Research
Studied Doses
2–25+ mg daily depending on study
Common Clinical Dose
25 mg once daily
Longest Major Study
Up to 2 years
Main Finding
GH + IGF-1 increased
What makes MK-677 different:
MK-677 has been studied directly in humans, including longer-term randomized trials. Research consistently shows that it can increase natural GH release and raise IGF-1 levels. However, increasing GH and IGF-1 does not automatically mean every expected benefit—such as muscle gain, fat loss, or improved physical performance—will occur.
MK-677 has been studied directly in humans, including longer-term randomized trials. Research consistently shows that it can increase natural GH release and raise IGF-1 levels. However, increasing GH and IGF-1 does not automatically mean every expected benefit—such as muscle gain, fat loss, or improved physical performance—will occur.
Research Dosing Instructions
Dosing Format
Compound TypeOral GH secretagogue
Common FormatCapsule or liquid
ReconstitutionNot required
Dosing StyleMilligram-based oral dosing
Dose Reference
10 mg daily = common starting range
15 mg daily = common standard range
15–25 mg daily = higher real-world range
25 mg daily = upper common range discussed in many protocols
Important:
MK-677 does not use syringe units, vial math, or bacteriostatic water. It is usually taken orally and measured directly in milligrams.
MK-677 does not use syringe units, vial math, or bacteriostatic water. It is usually taken orally and measured directly in milligrams.
Storage & Shelf Life
Storage & Shelf Life
Capsules / Tablets
Store in a cool, dry place away from heat, humidity, and direct sunlight.
Keep tightly sealed in the original container when possible.
Avoid storing in bathrooms, cars, or humid areas.
Liquid Format
Follow the supplier’s label instructions for room-temperature or refrigerated storage.
Keep sealed and protected from heat and light.
Avoid contamination by keeping the dropper clean.
Use Window
Follow the expiration date listed by the supplier or manufacturer.
Discard if the product changes color, smell, texture, or becomes contaminated.
Best Practice
Handling
Keep MK-677 sealed, dry, and protected from heat to preserve quality.
Quality Check
If capsules soften, powder clumps from moisture, or liquid changes appearance or smell, it is safer not to continue using it.
Research Time Between Cycles
GH Support Phase → Reassess → Time Off → Repeat if Needed
Standard Research Time Between Cycles
Cycle Length8–16+ weeks
Time Off4–8 weeks
Review PointEvery 8–12 weeks
Why take a break?
MK-677 is often used longer than many short-cycle compounds because GH and IGF-1 changes build over time. However, breaks are commonly used to reassess hunger, water retention, lethargy, blood sugar response, and whether the compound is still providing a clear benefit.
MK-677 is often used longer than many short-cycle compounds because GH and IGF-1 changes build over time. However, breaks are commonly used to reassess hunger, water retention, lethargy, blood sugar response, and whether the compound is still providing a clear benefit.
Research Best Ways to Structure It
Option 18–12 weeks on, 4 weeks off
Good for a shorter recovery or sleep-support phase
Option 212–16 weeks on, 4–8 weeks off
Common for longer GH-support or body composition phases
Option 3Use during a targeted bulk or recovery block
Then stop once the phase ends and reassess appetite, water retention, and glucose response
When to Stop Sooner
Hunger becomes difficult to manage
Water retention becomes excessive
Blood sugar trends worsen
Lethargy becomes disruptive
Benefits feel flat or unclear
What Human Studies Found
GH + IGF-1
MK-677 consistently increased natural growth hormone release in human studies.
IGF-1 levels also increased significantly.
In one early study, 25 mg daily nearly doubled average 24-hour GH levels after two weeks.
Body Composition
A 2-year study in healthy older adults found that MK-677 helped increase fat-free mass.
The increase in fat-free mass did not translate into clear improvements in muscle strength or physical function.
The study did not show a significant reduction in abdominal visceral fat.
Blood Sugar + Appetite
Increased appetite is one of the most commonly reported effects.
Human studies have also found increases in fasting blood glucose and reduced insulin sensitivity.
Blood sugar monitoring becomes especially important during longer research phases.
Bottom line:
MK-677 clearly raises GH and IGF-1 in humans. The evidence for increased fat-free mass is also promising, but improvements in strength, performance, and fat loss are much less certain.
MK-677 clearly raises GH and IGF-1 in humans. The evidence for increased fat-free mass is also promising, but improvements in strength, performance, and fat loss are much less certain.
Monitoring During Use
Hunger levels, which can increase significantly
Sleep quality
Water retention
Body composition changes
Blood sugar response, especially during longer cycles
Benefits & Research Findings
Increases natural GH and IGF-1 levels
May support sleep and recovery
Has increased fat-free mass in human research
May influence bone turnover and bone-related markers
Convenient once-daily oral administration
Potential Side Effects
Increased appetite or hunger
Water retention or mild swelling
Possible lethargy or fatigue
Increased fasting blood sugar
Reduced insulin sensitivity in some users
Possible muscle or joint discomfort
Blood sugar matters:
MK-677 can affect glucose control even while increasing GH and IGF-1. This is one of the more important areas to monitor during longer research phases, especially when blood sugar is already a concern.
MK-677 can affect glucose control even while increasing GH and IGF-1. This is one of the more important areas to monitor during longer research phases, especially when blood sugar is already a concern.
Important Notes
Not a peptide; it is an oral GH secretagogue
Does not require reconstitution
Stimulates the body's own GH release rather than supplying growth hormone directly
Can increase hunger significantly
Longer use is common compared with short peptide cycles
Blood sugar awareness is important during longer use
Important Disclaimer
MK-677 is not FDA-approved and is considered a research compound. This content is for educational purposes only.
Research & References
Primary Research
- Chapman IM, Bach MA, Van Cauter E, et al. Stimulation of the Growth Hormone (GH)-Insulin-Like Growth Factor I Axis by Daily Oral Administration of a GH Secretagogue (MK-677) in Healthy Elderly Subjects. Journal of Clinical Endocrinology & Metabolism. 1996.
- Nass R, Pezzoli SS, Oliveri MC, et al. Effects of an Oral Ghrelin Mimetic on Body Composition and Clinical Outcomes in Healthy Older Adults: A Randomized Trial. Annals of Internal Medicine. 2008.
- Murphy MG, Bach MA, Plotkin D, et al. Oral Administration of the Growth Hormone Secretagogue MK-677 Increases Markers of Bone Turnover in Healthy and Functionally Impaired Elderly Adults. Journal of Bone and Mineral Research. 1999.
Comments
Post a Comment